News

Bivalirudin edges unfractionated heparin for PCI in acute coronary syndrome patients


 

AT ACC 15

References

MATRIX was an investigator-initiated study that received grant support from Terumo and the Medicines Co. Dr. Valgimigli had no disclosures. Dr. Jolly has been a consultant to AstraZeneca, a speaker on behalf of St. Jude, and received research grants from Medtronic. Dr. Kandzari has been a consultant to Medtronic and Boston Scientific and has received research support from Abbott Vascular, Biotronik, Boston Scientific, and Medtronic. Dr. Grines has been a consultant to and received honoraria from Abbott Vascular, the Medicines Co., Merck, and the Volcano Group.

mzoler@frontlinemedcom.com

On Twitter @mitchelzoler

Pages

Recommended Reading

SCOT-HEART: CT angiography scores big in stable chest pain
MDedge Cardiology
PCI linked to higher rate of cardiovascular events than CABG
MDedge Cardiology
Everolimus-eluting stents linked to higher MI risk than CABG
MDedge Cardiology
Transradial PCI outperforms transfemoral for acute coronary syndromes
MDedge Cardiology
VIDEO: Data support switching to transradial PCI access
MDedge Cardiology
Novel agent fails to reduce infarct size, but may cut heart failure, protect kidneys
MDedge Cardiology
Advanced age no barrier to aggressive heart attack treatment
MDedge Cardiology
Anticipation runs high for coming megatrials in general cardiology
MDedge Cardiology
Updated IMPROVE-IT results show bigger benefits
MDedge Cardiology
Gout increases risk of vascular disease, especially for women
MDedge Cardiology